From: Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy
Group
Breast cancer patients
ACE2 (ng/mL)
P-value
Chemo-resistant
57
17.46
< 0.0001
Chemo-sensitive
54
13.47